BIOMEDICA MANAGEMENT CORPORATION

HALETHORPE, MD · CIK 0001641333 · Medtech

ClotFoam, a novel adhesive sealant hemostatic agent for controlling moderate to severe blood loss from traumatic injury and intraoperative hemorrhage

Grants
$5K
1 award
Sector median: 1
Raised
$300K
2 Form D · May 2015
137 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$100,000
Private capital raised· 2 of 2 same dayForm D · SEC$200,000
Federal grantDepartment of Health and Human Services · Phase II · Clinical Development of Non-compressible Hemostatic Agent for High-Volume Hemorrhage$5,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1039Prana Interactive Inc.—$328K
1040DEXCOM INC—$11M
1041Aquillius Corporation——
1042BIOMEDICA MANAGEMENT CORPORATION—$300K
1043Lazurite Inc.—$9.1M
10442nd Skull, Inc.—$3.0M
1045PhotoniCare, Inc.—$19M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • George FalusExecutive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.